インクレチンbase薬 腸閉塞risk https://t.co/8ofNOKXrLv 腸閉塞⬆️HR1.69 GLP-1 RA 1.9/千人年 vs SGLT-2阻害剤1.1 最高HR3.48は1.6年使用後 DPP-4阻害剤⬆️関連2.7 vs 1 HR2.59 最高HR 9.53は 1.8年使用後 1 年使用後に有害に必要数 GLP-1 RA 1223 DPP-4阻害剤603 https://t…
3,724 followers
6,809 followers
@Bigapple2la Yeah this paper is just a letter to editor and some ideas around pharmacologic rationale but it seems to be a hot topic. UK comparison of risk between incretins and Sglt2. https://t.co/Ok6za9hrvU If real, will he more noticeable as we push …
6,809 followers
@AbuOlive Agree re: pancreatitis/chole. It's mostly been case reports and pharmacovigilance studies, with issues, and no attempt to control for risk factors. This UK paper comparing risk for incretin drugs vs SGLT2s is intriguing though. https://t.co/8…
1,102 followers
Incretin-Based Drugs and Risk of Intestinal Obstruction Among Patients With Type 2 Diabetes https://t.co/mTIdYYDvYb